About me
Andrew Emmett is Pfizer's FDA Liaison and Executive Director for U.S. Regulatory Policy & Global Intelligence. In his role, Andrew develops and advocates for Pfizer policy positions to enhance the regulatory environment for biomedical innovation. He leads key initiatives on real-world evidence, clinical trial modernization, expedited pathways, FDA user fee legislation, and other areas of regulatory reform. Prior to Pfizer, Andrew spent thirteen years with the Biotechnology Industry Organization (BIO) where he served as Managing Director for Science & Regulatory Affairs. He attended Cornell University and holds a Master’s of Public Health in healthcare policy from George Washington University.
